The proposed pharmacy reform in Germany is facing headwinds as criticism from pharmacists intensifies, prompting Health Minister Nina Warken (CDU) to pledge a future increase in the fixed payment, known as the “Fixum”. While acknowledging current budgetary constraints impacting the timing of the increase – a commitment previously made – Warken emphasized in an interview with “Rheinische Post” that the postponement does not invalidate the pledge. This maneuver aims to quell growing discontent within the pharmacy sector.
The reform itself proposes easing restrictions on opening hours and representation requirements for pharmacists, framed by Warken as a means of providing relief to pharmacies. However, anxieties within the industry regarding potential loopholes allowing for operation without qualified pharmacists have surfaced. Warken sought to assuage these fears, categorically stating that under her leadership, “there will be no pharmacies without pharmacists” directly addressing proposals that had previously circulated.
Despite the assurances, the need for “more flexible representation regulations” particularly in rural areas, remains a central tenet of the planned overhaul. The Minister characterized these changes as an “option, not an obligation” signalling an attempt to navigate concerns about reduced staffing levels while still allowing for adaptation to local conditions. The proposed adjustments to opening hours are also presented as a potentially beneficial step.
Critics argue that the delayed “Fixum” increase is a short-term fix that fails to address the fundamental challenges facing pharmacies, including profitability and workforce shortages. The carefully worded commitments regarding pharmacist presence are viewed by some as a reactive measure rather than a proactive solution to the underlying issues.
A cabinet discussion on the pharmacy reform is now scheduled for December, likely to be a contentious session given the divergent opinions and the ongoing pressure from both the pharmacy sector and the public. The ultimate success of the reform will hinge on the government’s ability to balance the needs of pharmacies with ensuring continued access to qualified pharmaceutical expertise.
